Laura Evgin

9PUBLICATIONS
74CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 05, 2026
Engagement of the TCR against an oncolytic virus generates a population of effector CAR T cells with potent antitumor activity.

|Mar 19, 2026
A gene-editing method generates immunotherapeutic CAR T cells in the body.

Robert Holt, Laura Evgin

|Nov 21, 2025
Phenotypic Characterization and Prognostic Impact of CD103+ Tissue-Resident Memory T Cells in Diffuse Large B-cell Lymphoma.

Gillian Savage, Katy Milne, Brett Collinge

|Jun 20, 2025
Somatic IRF4 mutations and thymic tropism in primary mediastinal large B-cell lymphoma.

Shinya Rai, Gerben Duns, Fabian Frontzek

|Jun 27, 2024
Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response.

Mason J Webb, Thanich Sangsuwannukul, Jacob van Vloten

|Dec 04, 2023
Chimerization of the Anti-Viral CD8<sup>+</sup> T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic Virotherapy.

Richard Vile, Mason Webb, Jacob van Vloten

Pageof 2

Frequent Collaborators

3 joint publications

Richard Vile

3 joint publications

Alan Melcher

2 joint publications

David W Scott

2 joint publications

Jill Thompson